Dr. Dunbar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5132 Rockville Pike
Rm 4E
Bethesda, MD 20892Phone+1 301-496-5093Fax+1 301-594-1290
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1984 - 1987
Harvard Medical SchoolClass of 1984
Certifications & Licensure
MD State Medical License 1989 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2003
Clinical Trials
- Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives Start of enrollment: 1996 Mar 18
- Screening for Hematology Branch Protocols Start of enrollment: 1996 Dec 31
- A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients Start of enrollment: 2009 May 29
- Join now to see all
Publications & Presentations
PubMed
- Progress toward the challenging goal of HDR-based gene editing for hyper-IgM syndrome.Luiz Fernando Bazzo Catto, Cynthia E Dunbar
Molecular Therapy. Methods & Clinical Development. 2024-12-12 - T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities.Jingqiong Hu, Cynthia E Dunbar
Blood. 2024-12-12 - 2 citationsClonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations.Fernanda Gutierrez-Rodrigues, Emma M Groarke, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, Luiz Fernando B Catto
Blood. 2024-12-05
Abstracts/Posters
- An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human PrimatesCynthia E. Dunbar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Modeling Human Paroxysmal Nocturnal Hemoglobinuria Via CRISPR/Cas9 HSPC Gene Editing in Non-Human Primate2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALLDecember 8th, 2024- Bispecific Combo New Standard for Pediatric Acute Lymphoblastic Leukemia, Experts SayDecember 7th, 2024
- ASH 2024: What Blood Cancer Advances Could Change Practice?December 2nd, 2024
- Join now to see all
Grant Support
- The Rhesus Macaque As A Preclinical Model For Induced Pluripotent Stem CellsNational Heart, Lung, And Blood Institute2010–2011
- Retroviral Mediated Gene Transfer Into Primate Hematopoietic CellsNational Heart, Lung, And Blood Institute2010–2011
- Enhancement Of Hematopoietic Stem Cell Mobilization And EngraftmentNational Heart, Lung, And Blood Institute2010–2011
- Developing Efficient And SAFE Gene Transfer To Primate Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2010–2011
- Gene Transfer And Ex Vivo Manipulation Of Stem CellsNational Heart, Lung, And Blood Institute2009
- Gene Transfer And Ex Vivo Manipulation Of Hematopoietic CellsNational Heart, Lung, And Blood Institute1998–2008
- Gene Transfer And Ex Vivo Manipulation Of HematopoieticNational Heart, Lung, And Blood Institute2001–2006
- Gene Transfer To Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1995–1997
- Gene Transfer To Human Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1994
- Preclinical And Clinical Gene Transfer To Human Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
